PhenX - gastroesophageal reflux disease (GERD) symptoms protocol 191101

General Details:

Name:: PhenX - gastroesophageal reflux disease (GERD) symptoms protocol 191101
Steward:: NICHD
Definition:: The Gastroesophageal Reflux Disease Questionnaire (GerdQ) is a 6-item questionnaire that helps identify patients with gastroesophageal reflux disease (GERD). Patients are asked to report frequency of symptoms over the past 7 days. If the administration of the GerdQ produces a positive score for GERD, the Gastrointestinal Working Group (WG) recommends performing a pH impedence test to confirm the results and determine disease severity. Please see the Gastrointestinal WG Supplemental Information for a pH impedence test protocol. The Gastroesophageal Reflux Disease Questionnaire (GerdQ) is a proprietary instrument that is available for use with permission from AstraZeneca. To obtain permission, contact AstraZeneca at PROinformation@astrazeneca.com and complete a License Agreement.
Registration Status:: Qualified

Value	Code Name	Code	Code System	Code Description

Designation:: PhenX - gastroesophageal reflux disease (GERD) symptoms protocol 191101
Tags:: Long Common Name

Definition:: The Gastroesophageal Reflux Disease Questionnaire (GerdQ) is a 6-item questionnaire that helps identify patients with gastroesophageal reflux disease (GERD). Patients are asked to report frequency of symptoms over the past 7 days. If the administration of the GerdQ produces a positive score for GERD, the Gastrointestinal Working Group (WG) recommends performing a pH impedence test to confirm the results and determine disease severity. Please see the Gastrointestinal WG Supplemental Information for a pH impedence test protocol. The Gastroesophageal Reflux Disease Questionnaire (GerdQ) is a proprietary instrument that is available for use with permission from AstraZeneca. To obtain permission, contact AstraZeneca at PROinformation@astrazeneca.com and complete a License Agreement.
Tags:: Source: Regenstrief LOINC

ID:
Title:
URI:
Provider Org:
Language Code:: en-US
Document:: Jones, R., Junghard, O., Dent, J., Vakil, N., Halling, K., Wernersson, B., & Lind, T. (2009). Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care. Alimentary Pharmacology and Therapeutics, 30(10), 1030–1038.

ID:
Title:
URI:
Provider Org:
Language Code:: en-US
Document:: Chehade, R. J., Lacy, B. E., & Crowell, M. D. (2010, May). Gastroesophageal reflux disease: A prospective study comparing a symptom-based reflux disease questionnaire to BRAVO pH capsule monitoring. Poster presented at the Digestive Disease Week conference, New Orleans, LA.

ID:
Title:
URI:
Provider Org:
Language Code:: en-US
Document:: Vakil, N., van Zanten, S. V., Kahrilas, P., Dent, J., & Jones, R. (2007). The Montreal definition and classification of gastroesophageal reflux disease: A global evidence-based consensus. American Journal of Gastroenterology, 101(8), 1900–1920.

Key:

Related Names

Value:

Key:

Related Codes

Value:

Code System	Code	Code Text	Code Version
https://www.phenxtoolkit.org	191101	gastroesophageal_reflux_disease_(gerd)_symptoms

Key:

Fully-Specified Name

Value:

Component	Property	Time	System	Scale	Method
PhenX - gastroesophageal reflux disease (GERD) symptoms protocol 191101	-	Pt	^Patient	-	PhenX

Key:

Basic Attributes

Value:

Class	Type	First Released	Last Updated	Change Reason	Panel Type
PANEL.PHENX	Clinical	Version 2.36	Version 2.66	Updated the PhenX ID from "PhenX." to "PX" in Survey Question Source field to align with the variable identifier used in the PhenX Toolkit.; Added the PhenX protocol ID to the Component to clearly define the protocol version for which this panel is based upon.	Panel